Old Web
English
Sign In
Acemap
>
Paper
>
Hepatotoxicity is the risk factor with gemtuzumab ozogamicin treatment in acute myelogenous leukaemia patients.
Hepatotoxicity is the risk factor with gemtuzumab ozogamicin treatment in acute myelogenous leukaemia patients.
2020
Sayed Aliul Hasan Abdi
Shatrunajay Shukla
Jasim Khan
Abdulaziz Al Zahrani
Keywords:
Oncology
Acute myelogenous leukaemia
Internal medicine
Gemtuzumab ozogamicin
Risk factor
Medicine
Diabetes mellitus
Pathology
Correction
Source
Cite
Save
Machine Reading By IdeaReader
11
References
0
Citations
NaN
KQI
[]